157 related articles for article (PubMed ID: 1391253)
1. The fibrinolytic system in the newborn: role of histidine-rich glycoprotein.
Caccamo ML; Rossi E; Salmoiraghi MG; Mondonico P; Gianotti GA; Marini A
Biol Neonate; 1992; 61(5):281-4. PubMed ID: 1391253
[TBL] [Abstract][Full Text] [Related]
2. The role of alpha 2-antiplasmin in the inhibition of clot lysis in newborns and adults.
Ries M; Klinge J; Rauch R; Keuper H; Harms D
Biol Neonate; 1996; 69(5):298-306. PubMed ID: 8790908
[TBL] [Abstract][Full Text] [Related]
3. Histidine-rich glycoprotein and plasminogen plasma levels in term and preterm newborns.
Corrigan JJ; Jeter MA
Am J Dis Child; 1990 Jul; 144(7):825-8. PubMed ID: 2356801
[TBL] [Abstract][Full Text] [Related]
4. Fibrinolysis--a review.
Kane KK
Ann Clin Lab Sci; 1984; 14(6):443-9. PubMed ID: 6239587
[TBL] [Abstract][Full Text] [Related]
5. The influence of L-asparaginase therapy on the fibrinolytic system.
Vellenga E; Kluft C; Mulder NH; Wijngaards G; Nieweg HO
Br J Haematol; 1984 Jun; 57(2):247-54. PubMed ID: 6203549
[TBL] [Abstract][Full Text] [Related]
6. [Characteristics of the fibrinolytic system in the newborn].
Schlegel N; Hurtaud-Roux MF; Beaufils F
Ann Pediatr (Paris); 1993 Feb; 40(2):70-4. PubMed ID: 8457135
[TBL] [Abstract][Full Text] [Related]
7. Fibrinolysis and thrombosis of fibrinogen-modified gold nanoparticles for detection of fibrinolytic-related proteins.
Jian JW; Chiu WC; Chang HT; Hsu PH; Huang CC
Anal Chim Acta; 2013 Apr; 774():67-72. PubMed ID: 23567118
[TBL] [Abstract][Full Text] [Related]
8. The influence of age on in vitro plasmin generation in the presence of fibrin monomer.
Parmar N; Mitchell LG; Berry LR; Andrew M; Chan AK
Acta Haematol; 2006; 115(3-4):141-51. PubMed ID: 16549888
[TBL] [Abstract][Full Text] [Related]
9. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.
Meijers JC; Middeldorp S; Tekelenburg W; van den Ende AE; Tans G; Prins MH; Rosing J; Büller HR; Bouma BN
Thromb Haemost; 2000 Jul; 84(1):9-14. PubMed ID: 10928462
[TBL] [Abstract][Full Text] [Related]
10. alpha 2-Antiplasmin Enschede: dysfunctional alpha 2-antiplasmin molecule associated with an autosomal recessive hemorrhagic disorder.
Kluft C; Nieuwenhuis HK; Rijken DC; Groeneveld E; Wijngaards G; van Berkel W; Dooijewaard G; Sixma JJ
J Clin Invest; 1987 Nov; 80(5):1391-400. PubMed ID: 2445779
[TBL] [Abstract][Full Text] [Related]
11. Plasminogen activators in alcoholic cirrhosis: demonstration of increased tissue type and urokinase type activator.
Booth NA; Anderson JA; Bennett B
J Clin Pathol; 1984 Jul; 37(7):772-7. PubMed ID: 6235248
[TBL] [Abstract][Full Text] [Related]
12. Plasminogen, alpha(2)-antiplasmin and complexes of plasmin-alpha(2)-antiplasmin (PAP) in amniotic fluid and blood plasma of parturient women.
Uszynski M; Klyszejko A; Zekanowska E
Eur J Obstet Gynecol Reprod Biol; 2000 Dec; 93(2):167-71. PubMed ID: 11074138
[TBL] [Abstract][Full Text] [Related]
13. Modified crossed immunoelectrophoresis to study with whole plasma the reversible complex formation of histidine-rich glycoprotein with plasminogen.
Kluft C; Los P
Thromb Haemost; 1988 Dec; 60(3):411-4. PubMed ID: 2467400
[TBL] [Abstract][Full Text] [Related]
14. The impact of the fibrinolytic system on the risk of venous and arterial thrombosis.
Meltzer ME; Doggen CJ; de Groot PG; Rosendaal FR; Lisman T
Semin Thromb Hemost; 2009 Jul; 35(5):468-77. PubMed ID: 19739037
[TBL] [Abstract][Full Text] [Related]
15. An enzyme-linked immunosorbent assay (ELISA) for the measurement of plasmin-alpha 2-antiplasmin complex in human plasma--application to the detection of in vivo activation of the fibrinolytic system.
Holvoet P; de Boer A; Verstreken M; Collen D
Thromb Haemost; 1986 Oct; 56(2):124-7. PubMed ID: 2433784
[TBL] [Abstract][Full Text] [Related]
16. [The regulation of fibrinolysis].
Matsuo O
Nihon Rinsho; 1989 Apr; 47(4):739-45. PubMed ID: 2526261
[No Abstract] [Full Text] [Related]
17. Plasmin-alpha 2-antiplasmin complexes in bleeding disorders characterized by primary or secondary fibrinolysis.
Booth NA; Bennett B
Br J Haematol; 1984 Apr; 56(4):545-56. PubMed ID: 6201189
[TBL] [Abstract][Full Text] [Related]
18. Reduced histidine-rich glycoprotein levels in plasma of patients with advanced liver cirrhosis. Possible implications for enhanced fibrinolysis.
Saito H; Goodnough LT; Boyle JM; Heimburger N
Am J Med; 1982 Aug; 73(2):179-82. PubMed ID: 7114073
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the fibrinolytic system in full-term neonates.
Pinacho A; Páramo JA; Ezcurdia M; Rocha E
Int J Clin Lab Res; 1995; 25(3):149-52. PubMed ID: 8562978
[TBL] [Abstract][Full Text] [Related]
20. Changes in the coagulation and fibrinolytic systems during and after cardiopulmonary bypass surgery.
Kongsgaard UE; Smith-Erichsen N; Geiran O; Bjørnskau L
Thorac Cardiovasc Surg; 1989 Jun; 37(3):158-62. PubMed ID: 2527423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
